These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27644251)

  • 21. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
    Guo Z; Tang Y; Fu Y; Wang J
    Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
    Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    World J Surg Oncol; 2015 Nov; 13():323. PubMed ID: 26607846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
    Han J; Yong B; Luo C; Tan P; Peng T; Shen J
    World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
    Konno M; Hamabe A; Doki Y; Mori M; Ishii H
    Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.
    Li J; Yang Z; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
    Clin Transl Oncol; 2014 Feb; 16(2):200-7. PubMed ID: 23793810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.
    Yu G; Yu W; Jin G; Xu D; Chen Y; Xia T; Yu A; Fang W; Zhang X; Li Z; Xie K
    Mol Cancer; 2015 Nov; 14():193. PubMed ID: 26576639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of CRM1 is associated with prognosis in human osteosarcoma.
    Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
    Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells.
    Yuan P; Zhou Y; Wang R; Chen S; Wang Q; Xu Z; Liu Y; Yang H
    Biomed Res Int; 2020; 2020():8450606. PubMed ID: 32219144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
    Li H; Yan M; Wu X; Wang Y; Huang L
    Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
    Zhao Y; Shen L; Chen X; Qian Y; Zhou Q; Wang Y; Li K; Liu M; Zhang S; Huang X
    Histol Histopathol; 2015 Nov; 30(11):1313-20. PubMed ID: 25936600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.